How this company is working to treat opioid addiction

Drugmaker BioCorRx is seeking FDA approval for an implantable medication to block opioid cravings. BioCorRx Director Louis Lucido sits down with Yahoo Finance's Julie Hyman, Adam Shapiro, and Sibile Marcellus to discuss how the company works.

Advertisement